Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - RUDOLPH TECHNOLOGIES INC | Financial_Report.xls |
| EX-32.2 - EXHIBIT - RUDOLPH TECHNOLOGIES INC | a9302014ex322.htm |
| EX-31.2 - EXHIBIT - RUDOLPH TECHNOLOGIES INC | a9302014ex312.htm |
| EX-32.1 - EXHIBIT - RUDOLPH TECHNOLOGIES INC | a9302014ex321.htm |
| EX-10.1 - EXHIBIT - RUDOLPH TECHNOLOGIES INC | a9302014ex101.htm |
| EX-31.1 - EXHIBIT - RUDOLPH TECHNOLOGIES INC | a9302014ex311.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
___________________________
FORM 10-Q
__________________________
(Mark One) | |
x | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the Quarterly Period Ended September 30, 2014
OR
o | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to
Commission File No. 000-27965
___________________________
RUDOLPH TECHNOLOGIES, INC.
(Exact name of registrant as specified in its charter)
___________________________
Delaware | 22-3531208 | |
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification Number) | |
One Rudolph Road, PO Box 1000, Flanders, New Jersey 07836
(Address of principal executive offices, including zip code)
Registrant’s telephone number, including area code: (973) 691-1300
___________________________
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes [X] No [_]
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (Section 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes [X] No [_]
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definition of “large accelerated filer”, “accelerated filer”, and “smaller reporting company” in Rule 12b-2 of the Securities Exchange Act.
Large accelerated filer [ ] | Accelerated filer [ X ] | Non-accelerated filer [ ] | Smaller reporting company [ ] | |||
(Do not check if a smaller reporting company) | ||||||
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes [_] No [X]
The number of outstanding shares of the Registrant’s Common Stock on October 21, 2014 was 33,185,520.
TABLE OF CONTENTS
Item No. | Page | |
PART I FINANCIAL INFORMATION
Item 1. | ||
Item 2. | ||
Item 3. | ||
Item 4. | ||
PART II OTHER INFORMATION
Item 1. | ||
Item 1A. | ||
Item 2. | ||
Item 3. | ||
Item 4. | ||
Item 5. | ||
Item 6. | ||
PART I FINANCIAL INFORMATION
Item 1. Financial Statements
RUDOLPH TECHNOLOGIES, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands)
September 30, 2014 | December 31, 2013 | ||||||
(Unaudited) | |||||||
ASSETS | |||||||
Current Assets: | |||||||
Cash and cash equivalents | $ | 47,628 | $ | 80,790 | |||
Marketable securities | 114,857 | 86,582 | |||||
Accounts receivable, less allowance of $1,366 as of September 30, 2014 and $1,152 as of December 31, 2013 | 49,969 | 53,437 | |||||
Inventories, net | 65,829 | 61,351 | |||||
Prepaid expenses and other current assets | 23,774 | 14,804 | |||||
Total current assets | 302,057 | 296,964 | |||||
Property, plant and equipment, net | 12,244 | 13,058 | |||||
Goodwill | 22,495 | 22,553 | |||||
Identifiable intangible assets, net | 9,557 | 11,464 | |||||
Other assets | 28,847 | 27,323 | |||||
Total assets | $ | 375,200 | $ | 371,362 | |||
LIABILITIES AND STOCKHOLDERS’ EQUITY | |||||||
Current liabilities: | |||||||
Accounts payable and accrued liabilities | $ | 17,127 | $ | 12,772 | |||
Other current liabilities | 18,743 | 18,918 | |||||
Total current liabilities | 35,870 | 31,690 | |||||
Convertible senior notes | 53,997 | 51,751 | |||||
Other non-current liabilities | 9,657 | 8,918 | |||||
Total liabilities | 99,524 | 92,359 | |||||
Commitments and contingencies | |||||||
Stockholders’ equity: | |||||||
Common stock | 33 | 33 | |||||
Additional paid-in capital | 418,417 | 415,739 | |||||
Accumulated other comprehensive loss | (1,666 | ) | (1,795 | ) | |||
Accumulated deficit | (141,108 | ) | (134,974 | ) | |||
Total stockholders’ equity | 275,676 | 279,003 | |||||
Total liabilities and stockholders’ equity | $ | 375,200 | $ | 371,362 | |||
The accompanying notes are an integral part of these financial statements.
1
RUDOLPH TECHNOLOGIES, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share data)
(Unaudited)
Three Months Ended | Nine Months Ended | ||||||||||||||
September 30, | September 30, | ||||||||||||||
2014 | 2013 | 2014 | 2013 | ||||||||||||
Revenues | $ | 46,960 | $ | 44,044 | $ | 131,627 | $ | 131,753 | |||||||
Cost of revenues | 22,000 | 21,574 | 61,794 | 63,894 | |||||||||||
Gross profit | 24,960 | 22,470 | 69,833 | 67,859 | |||||||||||
Operating expenses: | |||||||||||||||
Research and development | 9,631 | 10,455 | 30,477 | 30,372 | |||||||||||
Selling, general and administrative | 10,262 | 10,054 | 42,328 | 30,825 | |||||||||||
Amortization | 567 | 666 | 1,907 | 1,930 | |||||||||||
Total operating expenses | 20,460 | 21,175 | 74,712 | 63,127 | |||||||||||
Operating income (loss) | 4,500 | 1,295 | (4,879 | ) | 4,732 | ||||||||||
Interest expense, net | 1,328 | 1,262 | 3,950 | 3,671 | |||||||||||
Other expense (income) | 337 | (4 | ) | 372 | (53 | ) | |||||||||
Income (loss) before income taxes | 2,835 | 37 | (9,201 | ) | 1,114 | ||||||||||
Provision (benefit) for income taxes | 3,833 | (215 | ) | (3,067 | ) | (290 | ) | ||||||||
Net income (loss) | $ | (998 | ) | $ | 252 | $ | (6,134 | ) | $ | 1,404 | |||||
Earnings (loss) per share: | |||||||||||||||
Basic | $ | (0.03 | ) | $ | 0.01 | $ | (0.18 | ) | $ | 0.04 | |||||
Diluted | $ | (0.03 | ) | $ | 0.01 | $ | (0.18 | ) | $ | 0.04 | |||||
Weighted average shares outstanding: | |||||||||||||||
Basic | 33,237 | 32,897 | 33,205 | 32,727 | |||||||||||
Diluted | 33,237 | 33,426 | 33,205 | 33,337 | |||||||||||
The accompanying notes are an integral part of these financial statements.
2
RUDOLPH TECHNOLOGIES, INC.
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
(In thousands)
(Unaudited)
Three Months Ended | Nine Months Ended | ||||||||||||||
September 30, | September 30, | ||||||||||||||
2014 | 2013 | 2014 | 2013 | ||||||||||||
Net income (loss) | $ | (998 | ) | $ | 252 | $ | (6,134 | ) | $ | 1,404 | |||||
Other comprehensive loss: | |||||||||||||||
Change in net unrealized gains (losses) on investments, net of tax | 161 | 2 | 188 | (39 | ) | ||||||||||
Change in currency translation adjustments | (286 | ) | 563 | (59 | ) | (385 | ) | ||||||||
Total comprehensive income (loss) | $ | (1,123 | ) | $ | 817 | $ | (6,005 | ) | $ | 980 | |||||
The accompanying notes are an integral part of these financial statements.
3
RUDOLPH TECHNOLOGIES, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
(Unaudited)
Nine Months Ended September 30, | |||||||
2014 | 2013 | ||||||
Cash flows from operating activities: | |||||||
Net income (loss) | $ | (6,134 | ) | $ | 1,404 | ||
Adjustments to reconcile net income to net cash and cash equivalents provided by (used in) operating activities: | |||||||
Amortization of intangibles and other | 1,912 | 2,113 | |||||
Amortization of convertible note discount and issuance costs | 2,514 | 2,261 | |||||
Depreciation | 3,042 | 3,105 | |||||
Foreign currency exchange loss (gain) | 372 | (53 | ) | ||||
Contingent consideration adjustments | (111 | ) | — | ||||
Share-based compensation | 4,741 | 3,035 | |||||
Provision for doubtful accounts and inventory valuation | 2,974 | 2,382 | |||||
Deferred income taxes | 65 | — | |||||
Changes in operating assets and liabilities, net of acquisitions | (11,361 | ) | (18,219 | ) | |||
Net cash and cash equivalents provided by (used in) operating activities | (1,986 | ) | (3,972 | ) | |||
Cash flows from investing activities: | |||||||
Purchases of marketable securities | (172,323 | ) | (81,731 | ) | |||
Proceeds from sales of marketable securities | 145,015 | 71,687 | |||||
Purchases of property, plant and equipment | (1,442 | ) | (4,002 | ) | |||
Purchase of business | (3,365 | ) | |||||
Net cash and cash equivalents used in investing activities | (28,750 | ) | (17,411 | ) | |||
Cash flows from financing activities: | |||||||
Purchases of common stock | (2,330 | ) | — | ||||
Payment of contingent consideration for acquired business | (194 | ) | — | ||||
Proceeds from sales of shares through share-based compensation plans | 200 | 903 | |||||
Tax benefit for sale of shares through share-based compensation plans | 67 | 669 | |||||
Net cash and cash equivalents provided by (used in) financing activities | (2,257 | ) | 1,572 | ||||
Effect of exchange rate changes on cash and cash equivalents | (169 | ) | (662 | ) | |||
Net decrease in cash and cash equivalents | (33,162 | ) | (20,473 | ) | |||
Cash and cash equivalents at beginning of period | 80,790 | 104,253 | |||||
Cash and cash equivalents at end of period | $ | 47,628 | $ | 83,780 | |||
Supplemental disclosure of cash flow information: | |||||||
Income taxes paid | $ | 1,900 | $ | 5,261 | |||
Interest paid | $ | 2,250 | $ | 2,250 | |||
Litigation settlement paid - reflected in changes in operating assets and liabilities, net of acquisitions | $ | 10,613 | $ | — | |||
The accompanying notes are an integral part of these financial statements.
4
RUDOLPH TECHNOLOGIES, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(In thousands, except per share data)
(Unaudited)
NOTE 1. Basis of Presentation
The accompanying interim unaudited condensed consolidated financial statements have been prepared by Rudolph Technologies, Inc. (the “Company” or “Rudolph”) and in the opinion of management reflect all adjustments, consisting of normal recurring accruals, necessary for their fair presentation in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). Preparing financial statements requires management to make estimates and assumptions that affect amounts reported in the financial statements and accompanying notes. Actual amounts could differ materially from those amounts. The interim results for the three and nine month periods ended September 30, 2014 are not necessarily indicative of results to be expected for the entire year or any future periods. This interim financial information should be read in conjunction with the financial statements and the notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2013 (“2013 10-K”) filed with the Securities and Exchange Commission (“SEC”). The accompanying condensed consolidated balance sheet at December 31, 2013 has been derived from the audited consolidated financial statements included in the 2013 10-K.
Reclassifications
Certain prior period amounts have been reclassified to conform to current financial statement presentation. These amounts include the reclassification of a portion of deferred tax assets from Other assets to Prepaid expenses and other current assets in the Condensed Consolidated Balance Sheets.
Recent Accounting Pronouncements
In August 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2014-15, “Presentation of Financial Statements-Going Concern ( Subtopic 205-40 ), Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern.” This standard sets forth management’s responsibility to evaluate, each reporting period, whether there is substantial doubt about our ability to continue as a going concern, and if so, to provide related footnote disclosures. The standard is effective for annual and interim reporting periods ending after December 15, 2016. The Company is currently evaluating this new standard and expects it to have no impact on our financial position, results of operations, and cash flows.
In May 2014, the FASB issued ASU No. 2014-09, “Revenue from Contracts with Customers.” ASU 2014-09 outlines a comprehensive revenue recognition model and supersedes most current revenue recognition guidance. ASU 2014-09 will be effective for the Company starting in the first quarter of 2017. ASU 2014-09 allows for two methods of adoption: (a) “full retrospective” adoption, meaning the standard is applied to all periods presented, or (b) “modified retrospective” adoption, meaning the cumulative effect of applying ASU 2014-09 is recognized as an adjustment to the 2017 opening retained earnings balance. The Company is in the process of determining the adoption method as well as the effects the adoption of ASU 2014-09 will have on its consolidated financial position, results of operations, and cash flows.
NOTE 2. Fair Value Measurements
The Company applies a three-level valuation hierarchy for fair value measurements. This hierarchy prioritizes the inputs into three broad levels. Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2 inputs are quoted prices for similar assets and liabilities in active markets or inputs that are observable for the asset or liability, either directly or indirectly through market corroboration, for substantially the full term of the asset or liability. Level 3 inputs are unobservable inputs based on management’s assumptions used to measure assets and liabilities at fair value. A financial asset’s or liability’s fair value measurement classification within the hierarchy is determined based on the lowest level input that is significant to the fair value measurement.
5
The following tables provide the assets and liabilities carried at fair value measured on a recurring basis at September 30, 2014 and December 31, 2013:
Fair Value Measurements Using | ||||||||||||||||
Carrying Value | Quoted Prices in Active Markets for Identical Assets (Level 1) | Significant Other Observable Inputs (Level 2) | Significant Unobservable Inputs (Level 3) | |||||||||||||
September 30, 2014 | ||||||||||||||||
Assets: | ||||||||||||||||
Available-for-sale debt securities: | ||||||||||||||||
Municipal notes and bonds | $ | 114,857 | $ | — | $ | 114,857 | $ | — | ||||||||
Auction rate securities | — | — | — | — | ||||||||||||
Foreign currency forward contracts | 138 | $ | — | 138 | $ | — | ||||||||||
Total Assets | $ | 114,995 | $ | — | $ | 114,995 | $ | — | ||||||||
Liabilities: | ||||||||||||||||
Contingent consideration - acquisitions | $ | 4,903 | $ | — | $ | — | $ | 4,903 | ||||||||
Total Liabilities | $ | 4,903 | $ | — | $ | — | $ | 4,903 | ||||||||
December 31, 2013 | ||||||||||||||||
Assets: | ||||||||||||||||
Available-for-sale debt securities: | ||||||||||||||||
Municipal notes and bonds | $ | 86,305 | $ | — | $ | 86,305 | $ | — | ||||||||
Auction rate securities | 277 | — | — | 277 | ||||||||||||
Foreign currency forward contracts | 6 | — | 6 | — | ||||||||||||
Total Assets | $ | 86,588 | $ | — | $ | 86,311 | $ | 277 | ||||||||
Liabilities: | ||||||||||||||||
Contingent consideration - acquisitions | $ | 5,208 | $ | — | $ | — | $ | 5,208 | ||||||||
Total Liabilities | $ | 5,208 | $ | — | $ | — | $ | 5,208 | ||||||||
Level 1 investments are based on quoted prices that are available in active markets.
The Company’s investments classified as Level 2 are valued using observable inputs to quoted market prices, benchmark yields, reported trades, broker/dealer quotes or alternative pricing sources with reasonable levels of price transparency. The foreign currency forward contracts are primarily measured based on the foreign currency spot and forward rates quoted by the banks or foreign currency dealers. Available-for-sale debt securities prices are obtained from third party pricing providers, which models prices utilizing the above observable inputs, for each asset class.
Level 3 investments consist of an auction rate security and contingent consideration related to an acquisition for which the Company uses a discounted cash flow model to value these investments. The auction rate security was called and redeemed by the issuer during the three month period ended September 30, 2014. The auction rate security was redeemed for the full amount of $475. The Level 3 assumptions used in the discounted cash flow model for the contingent consideration included projected revenues, estimates of discount rates of 6.7% and timing of cash flows. A significant decrease in the projected revenues or increase in discount rate could result in a significantly lower fair value measurement for the contingent consideration.
6
This table presents a reconciliation for all assets and liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) for the nine months ended September 30, 2014:
Fair Value Measurements Using Significant Unobservable Inputs (Level 3) | ||||
Assets: | ||||
Balance at December 31, 2013 | $ | 277 | ||
Unrealized gain in accumulated other comprehensive loss | 198 | |||
Purchases | — | |||
Sales, issuances, and settlements | (475 | ) | ||
Transfers into (out of) Level 3 | — | |||
Balance at September 30, 2014 | $ | — | ||
Liabilities: | ||||
Balance at December 31, 2013 | $ | 5,208 | ||
Additions | — | |||
Total gain included in earnings | (111 | ) | ||
Payments | (194 | ) | ||
Transfers into (out of) Level 3 | — | |||
Balance at September 30, 2014 | $ | 4,903 | ||
See Note 3 for additional discussion regarding the fair value of the Company’s marketable securities.
Fair Value of Other Financial Instruments
The carrying value of cash and cash equivalents, accounts receivable, accounts payable and accrued liabilities approximates fair value because of the short-term maturity of these instruments. The estimated fair value of these obligations is based, primarily, on a market approach, comparing the Company’s interest rates to those rates the Company believes it would reasonably receive upon re-entry into the market. Judgment is required to estimate the fair value, using available market information and appropriate valuation methods.
The Company’s convertible senior notes are not publicly traded. The estimated fair value of the Company’s convertible senior notes was valued using a discounted cash flow model. The Level 3 assumptions, based on data available at the valuation date used in preparing the discounted cash flow model included estimates of interest rates, timing and amount of cash flows and expected holding periods of the convertible senior notes. The fair value of the contingent interest associated with the convertible senior notes is valued quarterly using the present value of expected cash flow model incorporating the probabilities of the contingent events occurring.
The following table reflects information pertaining to the Company’s convertible senior notes:
September 30, 2014 | December 31, 2013 | ||||||
Net carrying value of convertible senior notes | $ | 53,997 | $ | 51,751 | |||
Estimated fair value of convertible senior notes | $ | 59,832 | $ | 59,340 | |||
Estimated interest rate used in discounted cash flow model | 4.4 | % | 4.2 | % | |||
There was no contingent interest related to the Company’s convertible senior notes as of September 30, 2014 and December 31, 2013.
NOTE 3. Marketable Securities
The Company has evaluated its investment policies and determined that all of its investment securities are to be classified as available-for-sale. Available-for-sale securities are carried at fair value, with the unrealized gains and losses reported in Stockholders’ Equity under the caption “Accumulated other comprehensive loss.” Realized gains and losses on available-for-sale securities are included in “Other expense (income)” in the Condensed Consolidated Statements of Operations. The Company records other-than-temporary impairment charges for its available-for-sale investments when it intends to sell the securities, it is
7
more-likely-than not that it will be required to sell the securities before a recovery, or when it does not expect to recover the entire amortized cost basis of the securities. The cost of securities sold is based on the specific identification method.
At December 31, 2013, the Company held one auction rate security. The auction rate security was called and redeemed by the issuer during the three month period ended September 30, 2014. The auction rate security was redeemed for the full amount of $475.
The Company has determined that the gross unrealized losses on its marketable securities at September 30, 2014 and December 31, 2013 are temporary in nature. The Company reviews its investment portfolio to identify and evaluate investments that have indications of possible impairment. Factors considered in determining whether a loss is other-than-temporary include the length of time and extent to which fair value has been less than the cost basis, credit quality and the Company’s ability and intent to hold the investment for a period of time sufficient to allow for any anticipated recovery in market value.
At September 30, 2014 and December 31, 2013, marketable securities are categorized as follows:
Amortized Cost | Gross Unrealized Holding Gains | Gross Unrealized Holding Losses | Fair Value | |||||||||||||
September 30, 2014 | ||||||||||||||||
Municipal notes and bonds | $ | 114,820 | $ | 39 | $ | 2 | $ | 114,857 | ||||||||
Auction rate securities | — | — | — | — | ||||||||||||
Total marketable securities | $ | 114,820 | $ | 39 | $ | 2 | $ | 114,857 | ||||||||
December 31, 2013 | ||||||||||||||||
Municipal notes and bonds | $ | 86,257 | $ | 50 | $ | 2 | $ | 86,305 | ||||||||
Auction rate securities | 475 | — | 198 | 277 | ||||||||||||
Total marketable securities | $ | 86,732 | $ | 50 | $ | 200 | $ | 86,582 | ||||||||
The amortized cost and estimated fair value of marketable securities classified by the maturity date listed on the security, regardless of the Condensed Consolidated Balance Sheet classification, is as follows at September 30, 2014 and December 31, 2013:
September 30, 2014 | December 31, 2013 | |||||||||||||||
Amortized Cost | Fair Value | Amortized Cost | Fair Value | |||||||||||||
Due within one year | $ | 102,567 | $ | 102,595 | $ | 81,495 | $ | 81,533 | ||||||||
Due after one through five years | 12,253 | 12,262 | 4,762 | 4,772 | ||||||||||||
Due after five through ten years | — | — | — | — | ||||||||||||
Due after ten years | — | — | 475 | 277 | ||||||||||||
Total marketable securities | $ | 114,820 | $ | 114,857 | $ | 86,732 | $ | 86,582 | ||||||||
8
The following table summarizes the estimated fair value and gross unrealized holding losses of marketable securities, aggregated by investment instrument and period of time in an unrealized loss position at September 30, 2014 and December 31, 2013:
In Unrealized Loss Position For Less Than 12 Months | In Unrealized Loss Position For Greater Than 12 Months | |||||||||||||||
Fair Value | Gross Unrealized Losses | Fair Value | Gross Unrealized Losses | |||||||||||||
September 30, 2014 | ||||||||||||||||
Municipal notes and bonds | $ | 2,965 | $ | 2 | $ | — | $ | — | ||||||||
Auction rate securities | — | — | — | — | ||||||||||||
Total | $ | 2,965 | $ | 2 | $ | — | $ | — | ||||||||
December 31, 2013 | ||||||||||||||||
Municipal notes and bonds | $ | 16,448 | $ | 2 | $ | — | $ | — | ||||||||
Auction rate securities | — | — | 277 | 198 | ||||||||||||
Total | $ | 16,448 | $ | 2 | $ | 277 | $ | 198 | ||||||||
See Note 2 for additional discussion regarding the fair value of the Company’s marketable securities.
NOTE 4. Derivative Instruments and Hedging Activities
The Company, when it considers it to be appropriate, enters into forward contracts to hedge the economic exposures arising from foreign currency denominated transactions. At September 30, 2014 and December 31, 2013, these contracts included the future sale of Japanese Yen to purchase U.S. dollars. Derivative instruments are recognized as either “Prepaid expenses and other current assets” or “Other current liabilities” in the Condensed Consolidated Balance Sheets and are measured at fair value. The foreign currency forward contracts were entered into by the Company’s Japanese subsidiary to economically hedge a portion of certain intercompany obligations. The forward contracts are not designated as hedges for accounting purposes and an increase in the fair value of $132 and a decrease in the fair value of $259 for the nine month period ended September 30, 2014 and 2013, respectively, are recorded within the caption “Other expense (income)” in the Condensed Consolidated Statements of Operations.
The dollar equivalent of the U.S. dollar forward contracts and related fair values as of September 30, 2014 and December 31, 2013 were as follows:
September 30, 2014 | December 31, 2013 | ||||||
Notional amount | $ | 2,447 | $ | 1,029 | |||
Fair value of asset | $ | 138 | $ | 6 | |||
NOTE 5. Goodwill and Purchased Intangible Assets
Goodwill
The changes in the carrying amount of goodwill are as follows:
Balance at December 31, 2013 | $ | 22,553 | ||
Goodwill acquired during period | — | |||
Other | (58 | ) | ||
Balance at September 30, 2014 | $ | 22,495 | ||
9
Purchased Intangible Assets
Purchased intangible assets as of September 30, 2014 and December 31, 2013 are as follows:
Gross Carrying Amount | Accumulated Amortization | Net | ||||||||||
September 30, 2014 | ||||||||||||
Finite-lived intangibles: | ||||||||||||
Developed technology | $ | 59,831 | $ | 53,015 | $ | 6,816 | ||||||
Customer and distributor relationships | 9,560 | 7,730 | 1,830 | |||||||||
Trade names | 4,361 | 3,450 | 911 | |||||||||
Total identifiable intangible assets | $ | 73,752 | $ | 64,195 | $ | 9,557 | ||||||
December 31, 2013 | ||||||||||||
Finite-lived intangibles: | ||||||||||||
Developed technology | $ | 59,831 | $ | 51,496 | $ | 8,335 | ||||||
Customer and distributor relationships | 9,560 | 7,449 | 2,111 | |||||||||
Trade names | 4,361 | 3,343 | 1,018 | |||||||||
Total identifiable intangible assets | $ | 73,752 | $ | 62,288 | $ | 11,464 | ||||||
Intangible asset amortization expense for the three and nine months ended September 30, 2014 was $567 and $1,907, respectively. For the three and nine months ended September 30, 2013, intangible assets amortization expense was $666 and $1,930, respectively. Assuming no change in the gross carrying value of identifiable intangible assets and estimated lives, estimated amortization expense for the remainder of 2014 will be $515, and for each of the next five years estimated amortization expense amounts to $2,050 for 2015, $1,941 for 2016, $1,553 for 2017, $1,117 for 2018, and $1,117 for 2019.
NOTE 6. Balance Sheet Details
Inventories
Inventories are comprised of the following:
September 30, 2014 | December 31, 2013 | |||||||
Materials | $ | 29,822 | $ | 31,194 | ||||
Work-in-process | 26,437 | 19,867 | ||||||
Finished goods | 9,570 | 10,290 | ||||||
Total inventories | $ | 65,829 | $ | 61,351 | ||||
The Company has established reserves of $6,878 and $6,101 as of September 30, 2014 and December 31, 2013, respectively, for slow moving and obsolete inventory, which are included in the amounts above.
10
Property, Plant and Equipment
Property, plant and equipment, net is comprised of the following:
September 30, 2014 | December 31, 2013 | ||||||
Land and building | $ | 5,024 | $ | 5,024 | |||
Machinery and equipment | 21,322 | 20,827 | |||||
Furniture and fixtures | 3,498 | 4,043 | |||||
Computer equipment | 6,183 | 5,568 | |||||
Leasehold improvements | 7,797 | 7,744 | |||||
43,824 | 43,206 | ||||||
Less: Accumulated depreciation | 31,580 | 30,148 | |||||
Total property, plant and equipment, net | $ | 12,244 | $ | 13,058 | |||
Other assets
Other assets is comprised of the following:
September 30, 2014 | December 31, 2013 | |||||||
Deferred income taxes | $ | 27,377 | $ | 25,547 | ||||
Other | 1,470 | 1,776 | ||||||
Total other assets | $ | 28,847 | $ | 27,323 | ||||
Other current liabilities
Other current liabilities is comprised of the following:
September 30, 2014 | December 31, 2013 | |||||||
Litigation accrual | $ | 3,259 | $ | 4,293 | ||||
Deferred revenue | 8,536 | 8,383 | ||||||
Contingent consideration - acquisitions | 583 | 868 | ||||||
Other | 6,365 | 5,374 | ||||||
Total other current liabilities | $ | 18,743 | $ | 18,918 | ||||
Other non-current liabilities
Other non-current liabilities is comprised of the following:
September 30, 2014 | December 31, 2013 | |||||||
Unrecognized tax benefits (including interest) | $ | 3,537 | $ | 2,806 | ||||
Contingent consideration - acquisitions | 4,320 | 4,340 | ||||||
Other | 1,800 | 1,772 | ||||||
Total other non-current liabilities | $ | 9,657 | $ | 8,918 | ||||
NOTE 7. Debt Obligations
On July 25, 2011, the Company issued $60,000 aggregate principal amount of 3.75% Convertible Senior Notes due 2016 (the “Notes”) at par. The Notes were issued pursuant to an indenture, dated as of July 25, 2011, between the Company and Bank of New York Mellon Trust Company, N.A., as Trustee, which includes a form of Note. The Notes provide for the payment of interest semi-annually in arrears on January 15 and July 15 of each year, beginning January 15, 2012, at an annual rate of 3.75%
11
and will mature on July 15, 2016, unless earlier converted or repurchased. The Notes may be converted, under certain circumstances, based on an initial conversion rate of 77.241 shares of Company common stock per $1 principal amount of Notes, which represents an initial conversion price of approximately $12.95 per share. Concurrently with the issuance of the Notes, the Company purchased a convertible note hedge and sold a warrant. Each of the convertible note hedge and warrant transactions were entered into with an affiliate of the initial purchaser of the Notes. The convertible note hedge is intended to reduce the potential future dilution to the Company’s common stock associated with the conversion of the Notes. However, the warrant transaction will have a dilutive effect on the Company’s earnings per share to the extent that the price of the Company’s common stock exceeds the strike price of the warrant. The strike price of the warrant is $17.00 per share subject to adjustment in accordance with the terms of the agreement. The net proceeds to the Company from the sale of the Notes, including the convertible note hedge and warrant were $50,249.
The following table reflects the net carrying value of the Notes:
September 30, 2014 | December 31, 2013 | ||||||
Convertible senior notes | $ | 60,000 | $ | 60,000 | |||
Less: Unamortized interest discount | 6,003 | 8,249 | |||||
Net carrying value of convertible senior notes | $ | 53,997 | $ | 51,751 | |||
The following table presents the amount of interest cost recognized relating to the Notes during the three and nine months ended September 30, 2014 and September 30, 2013.
Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||
2014 | 2013 | 2014 | 2013 | ||||||||||||
Contractual interest coupon | $ | 563 | $ | 562 | $ | 1,688 | $ | 1,686 | |||||||
Amortization of interest discount | 772 | 700 | 2,246 | 2,037 | |||||||||||
Amortization of debt issuance costs | 94 | 79 | 268 | 224 | |||||||||||
Total interest cost recognized | $ | 1,429 | $ | 1,341 | $ | 4,202 | $ | 3,947 | |||||||
The remaining bond discount of the Notes of $6,003, as of September 30, 2014, will be amortized over the remaining life of the Notes.
NOTE 8. Commitments and Contingencies
Warranty Reserves
The Company generally provides a warranty on its products for a period of twelve to fifteen months against defects in material and workmanship. The Company estimates the costs that may be incurred during the warranty period and records a liability in the amount of such costs at the time revenue is recognized. The Company’s estimate is based primarily on historical experience. The Company periodically assesses the adequacy of its recorded warranty liabilities and adjusts the amounts as necessary. Settlements of warranty reserves are generally associated with sales that occurred during the 12 to 15 months prior to the year-end and warranty accruals are related to sales during the year.
Changes in the Company’s warranty reserves are as follows:
Nine Months Ended September 30, | ||||||||
2014 | 2013 | |||||||
Balance, beginning of the period | $ | 1,551 | $ | 2,024 | ||||
Accruals | 1,471 | 1,511 | ||||||
Less: Usage | 1,527 | 2,018 | ||||||
Balance, end of the period | $ | 1,495 | $ | 1,517 | ||||
Warranty reserves are reported in the Condensed Consolidated Balance Sheets within the caption “Accounts payable and accrued liabilities.”
Legal Matters
From time to time, the Company is subject to legal proceedings and claims in the ordinary course of business. As previously disclosed, in December 2007, the Company completed the acquisition of specific assets and liabilities of the semiconductor division
12
of Applied Precision LLC (“Applied”). As a result of the acquisition, the Company assumed certain liabilities of Applied including a lawsuit filed in the United States District Court, District of Arizona, by Integrated Technology Corporation (“ITC”) which alleged Applied’s PrecisionPoint™, PrecisionWoRx® and ProbeWoRx® products infringed an ITC patent (Integrated Technology Corporation v. Rudolph Technologies, Inc., No. CV-06-2182-PHX-ROS). Prior to trial, the District Court ruled that such products sold prior to August of 2007 (the “pre-August 2007 tools”) infringed the ITC patent. At trial in December of 2011, a trial verdict was rendered in which the jury found that while the Company’s products manufactured after August of 2007 (the “post-August 2007 tools”) did not literally infringe ITC’s patent, the products were found to infringe under a rule known as the doctrine of equivalents, a legal principle which expands the language of patent claims to encompass products or processes which may otherwise be found not to literally infringe the patent. The jury awarded $15,475 to ITC in damages for sales made during the years 2000-2011, of which award approximately one-half related to sales for pre-August 2007 tools. The jury found that for the sales of the post-August 2007 tools, the infringement was willful. On July 23, 2012, the District Court issued an Order which affirmed the jury’s award, applied treble damages to the portion of the jury award related to post-August 2007 tool sales and granted ITC’s motion for attorney’s fees and prejudgment interest on the verdict and attorney’s fees. At that time, the District Court also enjoined the Company from future infringement of the ITC patent and from selling or supplying the applicable products with the applicable features from or into the United States. The Company appealed the injunction, the District Court Order and the damages assessment. In October 2012, the injunction was stayed by the U.S. Federal Court of Appeals and thereafter in June of 2013, the patent expired. On November 4, 2013, the U.S. Federal Court of Appeals issued a ruling which reversed the judgment of infringement against all post-August 2007 tools, reversed the finding of willfulness, vacated the treble damages award, vacated the award of attorney’s fees and costs, remanded the issue back to the District Court for further review, and affirmed the award of damages and interest for the pre-August 2007 tools. As a result of this ruling, the matter was resolved with regard to the alleged infringement of the post-August 2007 tools in the Company’s favor. With regard to the damages assessment against the pre-August 2007 tools, on March 4, 2014, the Company filed a Petition for a Writ of Certiorari with the U.S. Supreme Court to appeal the basis of the Federal Court of Appeals’ decision affirming the damages award for the pre-August 2007 tools. On June 30, 2014, the Supreme Court denied the Company’s Petition. On July 22, 2014, the Company then paid to ITC $10,613 which represented only the damages and interest portion of the judgment. Since the patent expired in June of 2013 and payment of the judgment has been made, this matter is fully resolved with the sole exception of the issue of the remanded attorney’s fees. On August 8, 2014, the District Court issued an order for setting the attorney’s fees award at $3,252 which the Company appealed to the U.S. Federal Court of Appeals on September 5, 2014. The Company believes that it has meritorious defenses regarding this issue and intends to continue to vigorously prosecute the matter. The $3,252 is held in escrow and is recorded in “Prepaid expenses and other current assets” in the Condensed Consolidated Balance Sheets. The corresponding liability is recorded under the caption, “Other current liabilities,” in the Condensed Consolidated Balance Sheets. The Company expects this to be the maximum liability reasonably possible for the attorney’s fees, excluding interest, for this lawsuit with respect to both the pre-August 2007 and post-2007 August tools.
In the Company’s patent infringement suit against Camtek, Ltd., of Migdal Hamek, Israel, concerning the Company’s proprietary continuous scan wafer inspection technology, the U.S. Federal Court of Appeals issued a ruling on August 22, 2011. In its opinion, the Appellate Court affirmed multiple rulings from trial at the District Court level including (i) finding the Company’s U.S. Patent No. 6,826,298 valid, (ii) the part of the infringement ruling based on the finding that Camtek’s Falcon product strobes “based on velocity,” and (iii) the dismissal of Camtek’s claim against the Company for inequitable conduct against the U.S. Patent and Trademark Office. The court did, however, revise one claim construction ruling made by the District Court in the original case. As a result, the Appellate Court set aside the verdict delivered by the jury for damages and the District Court’s decision to enter an injunction against Camtek’s selling Falcon tools in the U.S. and remanded the case back to the trial court for a limited trial on this single infringement issue. On March 31, 2014, the District Court ruled in the Company’s favor, finding that Camtek’s Falcon tools continue to infringe the Company’s patent even under the revised claim construction of the patent, obviating the need for the limited trial. The Company intends to petition the court to reinstate a permanent injunction against the sale by Camtek of its infringing semiconductor inspection systems. The Company also anticipates that the damages originally awarded by the jury in 2009 will be reinstated, as well as related interest and all subsequently awarded damages. This lawsuit was initially brought in 2005 by August Technology prior to its merger with the Company. A subsequent lawsuit has been filed by Rudolph against Camtek alleging infringement of Rudolph’s U.S. Patent No. 7,729,528, also related to the Company’s proprietary continuous scan wafer inspection technology. This lawsuit is currently stayed pending resolution of a re-examination petition filed by Camtek with the U.S. Patent and Trademark Office.
Letter of Credit
The Company had a $40,000 irrevocable standby letter of credit with Credit Suisse AG available to secure the damages assessment in connection with the ITC litigation discussed in Legal Matters above. On July 22, 2014, the Company paid $10,613 to ITC through a draw down of the letter of credit. Pursuant to the terms of the letter of credit, upon draw down of the funds, the letter of credit was collateralized by securities held in the Company’s investment portfolios which were immediately sold to satisfy the letter of credit payment. The letter of credit was subsequently canceled upon completion of this payment.
13
NOTE 9. Share-Based Compensation
Restricted Stock Unit Activity
A summary of the Company’s nonvested restricted stock unit activity with respect to the nine months ended September 30, 2014 is as follows:
Number of Shares | Weighted Average Grant Date Fair Value | ||||||
Nonvested at December 31, 2013 | 1,116 | $ | 9.73 | ||||
Granted | 616 | $ | 10.91 | ||||
Less: Vested | 442 | $ | 8.60 | ||||
Less: Forfeited | 43 | $ | 10.52 | ||||
Nonvested at September 30, 2014 | 1,247 | $ | 10.68 | ||||
As of September 30, 2014 and December 31, 2013, there was $7,287 and $5,755 of total unrecognized compensation cost related to restricted stock units granted under the Company’s stock plans, respectively. That cost is expected to be recognized over a weighted average period of 2.6 years and 2.0 years for the respective periods.
NOTE 10. Other Expense (Income)
Three Months Ended | Nine Months Ended | ||||||||||||||
September 30, | September 30, | ||||||||||||||
2014 | 2013 | 2014 | 2013 | ||||||||||||
Foreign currency exchange losses (gains), net | $ | 337 | $ | (4 | ) | $ | 372 | $ | (53 | ) | |||||
Total other expense (income) | $ | 337 | $ | (4 | ) | $ | 372 | $ | (53 | ) | |||||
NOTE 11. Income Taxes
The following table provides details of income taxes:
Three Months Ended | Nine Months Ended | ||||||||||||||
September 30, | September 30, | ||||||||||||||
2014 | 2013 | 2014 | 2013 | ||||||||||||
Income (loss) before income taxes | $ | 2,835 | $ | 37 | $ | (9,201 | ) | $ | 1,114 | ||||||
Provision (benefit) for income taxes | $ | 3,833 | $ | (215 | ) | $ | (3,067 | ) | $ | (290 | ) | ||||
Effective tax rate | 135.2 | % | (581.1 | )% | 33.3 | % | (26.0 | )% | |||||||
The income tax provision for the three and nine months ended September 30, 2014 was computed based on the Company’s annual forecast of profit by jurisdiction and forecasted effective tax rate for the year. The effective tax rates for the three month periods ended September 30, 2014 and 2013 were impacted by changes in the Company’s annual earnings forecast which resulted in cumulative catch up adjustments being recorded in the period. The changes in the Company’s effective tax rate for the nine months ended September 30, 2014 compared to the same period for the prior year are primarily due to the generation of federal R&D credits for both 2012 and 2013 recognized in 2013, which are not available in the 2014 period as a result of legislation, and an increase in foreign tax expense in excess of foreign tax credits generated in 2014.
The Company currently has a partial valuation allowance recorded against certain deferred tax assets. Each quarter, the Company assesses the likelihood that it will be able to recover its deferred tax assets. The Company considers available evidence, both positive and negative, including prudent and feasible tax planning strategies in assessing the need for a valuation allowance. As a result of the Company’s analysis, it concluded that it is more likely than not that a portion of its deferred tax assets will not be realized. Therefore, the Company continues to provide a valuation allowance against certain deferred tax assets. The Company continues to closely monitor available evidence and may reverse some or all of the remaining valuation allowance in future periods, if appropriate. The Company has a valuation allowance of $1,646 as of September 30, 2014 and December 31, 2013.
14
NOTE 12. Earnings (Loss) Per Share
Basic earnings (loss) per share is calculated using the weighted average number of shares of common stock outstanding during the period. Diluted earnings per share is computed in the same manner and also gives effect to all dilutive common equivalent shares outstanding during the period. Potential common shares that would have the effect of increasing diluted earnings per share are considered to be antidilutive. In accordance with U.S. GAAP, these shares were not included in calculating diluted earnings per share. For the three and nine months ended September 30, 2014, all outstanding restricted stock units of 1,247 and stock options of 654 were excluded from the computation of diluted loss per share because the effect in the period would be antidilutive. For the three and nine months ended September 30, 2013, the weighted average number of stock options and restricted stock units excluded from the computation of diluted earnings per share totaled 672 and 731, respectively, because their effect was antidilutive. Diluted earnings per share-weighted average shares outstanding do not include any effect resulting from assumed conversion of the Notes and warrants as their impact would be antidilutive.
The Company’s basic and diluted earnings (loss) per share amounts are as follows:
Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||
2014 | 2013 | 2014 | 2013 | ||||||||||||
Numerator: | |||||||||||||||
Net income (loss) | $ | (998 | ) | $ | 252 | $ | (6,134 | ) | $ | 1,404 | |||||
Denominator: | |||||||||||||||
Basic earnings (loss) per share - weighted average shares outstanding | 33,237 | 32,897 | 33,205 | 32,727 | |||||||||||
Effect of potential dilutive securities: | |||||||||||||||
Employee stock options and restricted stock units - dilutive shares | — | 529 | — | 610 | |||||||||||
Diluted earnings (loss) per share - weighted average shares outstanding | 33,237 | 33,426 | 33,205 | 33,337 | |||||||||||
Earnings (loss) per share: | |||||||||||||||
Basic | $ | (0.03 | ) | $ | 0.01 | $ | (0.18 | ) | $ | 0.04 | |||||
Diluted | $ | (0.03 | ) | $ | 0.01 | $ | (0.18 | ) | $ | 0.04 | |||||
NOTE 13. Accumulated Other Comprehensive Loss
Comprehensive income includes net income (loss), foreign currency translation adjustments, and net unrealized gains and losses on available-for-sale investments. See the unaudited Condensed Consolidated Statements of Comprehensive Income (Loss) for the effect of the components of comprehensive loss to our net income (loss).
The components of accumulated other comprehensive loss, net of tax, are as follows:
Foreign currency translation adjustments | Net unrealized losses on available-for-sale investments | Accumulated other comprehensive loss | ||||||||||
Beginning Balance, December 31, 2013 | $ | 1,645 | $ | 150 | $ | 1,795 | ||||||
Net current period other comprehensive loss | 59 | (188 | ) | (129 | ) | |||||||
Reclassifications | — | — | — | |||||||||
Ending balance, September 30, 2014 | $ | 1,704 | $ | (38 | ) | $ | 1,666 | |||||
15
NOTE 14. Segment Reporting and Geographic Information
The Company is engaged in the design, development, manufacture and support of high-performance control metrology, defect inspection, advanced packaging lithography and data analysis systems used by microelectronics device manufacturers. The Company and its subsidiaries currently operate in a single operating segment: the design, development, manufacture and support of high-performance process control defect inspection, metrology, and process control software systems used by microelectronics device manufacturers, and therefore have one reportable segment. The Company’s chief operating decision maker is the Chief Executive Officer. The chief operating decision maker allocates resources and assesses performance of the business and other activities at the reporting segment level.
The following table lists the different sources of revenue:
Three Months Ended | Nine Months Ended | |||||||||||||||||||||||||||
September 30, | September 30, | |||||||||||||||||||||||||||
2014 | 2013 | 2014 | 2013 | |||||||||||||||||||||||||
Systems and Software: | ||||||||||||||||||||||||||||
Inspection | $ | 23,134 | 49 | % | $ | 21,734 | 49 | % | $ | 63,987 | 49 | % | $ | 73,441 | 55 | % | ||||||||||||
Metrology | 2,692 | 6 | % | 5,470 | 12 | % | 13,093 | 10 | % | 11,627 | 9 | % | ||||||||||||||||
Lithography | 7,304 | 16 | % | 3,618 | 8 | % | 10,961 | 8 | % | 7,318 | 6 | % | ||||||||||||||||
Data Analysis and Review | 5,463 | 12 | % | 4,724 | 11 | % | 18,393 | 14 | % | 13,737 | 10 | % | ||||||||||||||||
Parts | 4,939 | 10 | % | 5,235 | 12 | % | 15,051 | 11 | % | 16,036 | 13 | % | ||||||||||||||||
Services | 3,428 | 7 | % | 3,263 | 8 | % | 10,142 | 8 | % | 9,594 | 7 | % | ||||||||||||||||
Total revenue | $ | 46,960 | 100 | % | $ | 44,044 | 100 | % | $ | 131,627 | 100 | % | $ | 131,753 | 100 | % | ||||||||||||
For geographical revenue reporting, revenues are attributed to the geographic location in which the product is shipped. Revenue by geographic region is as follows:
Three Months Ended | Nine Months Ended | ||||||||||||||
September 30, | September 30, | ||||||||||||||
2014 | 2013 | 2014 | 2013 | ||||||||||||
United States | $ | 19,683 | $ | 13,484 | $ | 39,320 | $ | 32,962 | |||||||
Taiwan | 14,592 | 11,136 | 34,774 | 43,757 | |||||||||||
Japan | 1,236 | 2,345 | 7,589 | 6,052 | |||||||||||
China | 1,807 | 4,015 | 8,932 | 11,284 | |||||||||||
South Korea | 1,434 | 1,928 | 9,873 | 6,995 | |||||||||||
Other Asia | 1,942 | 5,552 | 14,528 | 14,127 | |||||||||||
Germany | 3,166 | 1,771 | 8,418 | 4,242 | |||||||||||
Other Europe | 3,100 | 3,813 | 8,193 | 12,334 | |||||||||||
Total revenue | $ | 46,960 | $ | 44,044 | $ | 131,627 | $ | 131,753 | |||||||
The following customers each accounted for more than 10% of total revenues for the indicated periods.
Nine Months Ended | |||||
September 30, | |||||
2014 | 2013 | ||||
Customer A | 7.4 | % | 13.0 | % | |
Customer B | 4.2 | % | 11.2 | % | |
16
NOTE 15. Share Repurchase Program
In 2008, the Board of Directors authorized a share repurchase program of up to 3,000 shares of the Company’s common stock with no established end date. The program allows for repurchases to be made in the open market or through negotiated transactions from time to time. At September 30, 2014, 2,762 shares remained available for future stock repurchases under this repurchase program. The shares of common stock purchased under the share repurchase program are being retired.
The Company did not repurchase any shares of its common stock during the three and nine month periods ended September 30, 2013. The following table summarizes the Company’s stock repurchases for the three and nine month periods ended September 30, 2014:
Three Months Ended | Nine Months Ended | ||||||
September 30, 2014 | September 30, 2014 | ||||||
Shares of common stock repurchased | 138 | 238 | |||||
Cost of stock repurchased | $1,344 | $2,331 | |||||
Average price paid per share | $9.78 | $9.81 | |||||
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
Certain statements in this Quarterly Report on Form 10-Q are forward-looking statements, including those concerning our business momentum and future growth, acceptance of our products and services, our ability to deliver both products and services consistent with our customers’ demands and expectations and strengthen our market position, our expectations of the semiconductor market outlook, future revenues, gross profits, research and development and engineering expenses, selling, general and administrative expenses, product introductions, technology development, manufacturing practices, cash requirements and anticipated trends and developments in and management plans for, our business and the markets in which we operate, our anticipated revenue as a result of acquisitions, and our ability to be successful in managing our cost structure and cash expenditures and results of litigation, including resolution of the remaining issue in our ITC litigation. The statements contained in this Quarterly Report on Form 10-Q that are not purely historical are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the words such as, but not limited to, “anticipate,” “believe,” “expect,” “intend,” “plan,” “should,” “may,” “could,” “will” and words or phrases of similar meaning, as they relate to our management or us.
The forward-looking statements contained herein reflect our current expectations with respect to future events and are subject to certain risks, uncertainties and assumptions. Actual results may differ materially from those projected in such forward-looking statements for a number of reasons including, but not limited to, the following: variations in the level of orders which can be affected by general economic conditions and growth rates in the semiconductor manufacturing industry and in the markets served by our customers, the global economic and political climates, difficulties or delays in product functionality or performance, the delivery performance of sole source vendors, the timing of future product releases, failure to respond adequately to either changes in technology or customer preferences, changes in pricing by us or our competitors, our ability to manage growth, risk of nonpayment of accounts receivable, changes in budgeted costs, our ability to leverage our resources to improve our position in our core markets, our ability to weather difficult economic environments, our ability to open new market opportunities and target high-margin markets, the strength/weakness of the back-end and /or front-end semiconductor market segments, our ability to successfully integrate acquired businesses into our business and fully realize, or realize within the expected time frame, the expected combination benefits from the acquisitions, and the “Risk Factors” set forth in Item 1A in our Annual Report on Form 10-K for the year ended December 31, 2013 (“2013 10-K”). The forward-looking statements reflect our position as of the date of this report and we undertake no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
Critical Accounting Policies
The preparation of condensed consolidated financial statements and related disclosures in conformity with accounting principles generally accepted in the United States (“U.S. GAAP”) requires management to make judgments, assumptions and estimates that affect the amounts reported. Certain of these significant accounting policies are considered to be critical accounting policies, as defined below.
A critical accounting policy is defined as one that is both material to the presentation of our condensed consolidated financial statements and requires management to make difficult, subjective or complex judgments that could have a material effect on our financial condition or results of operations. Specifically, these policies have the following attributes: (1) we are required to make judgments and assumptions about matters that are highly uncertain at the time of the estimate; and (2) different estimates
17
we could reasonably have used, or changes in the estimate that are reasonably likely to occur, could have a material effect on our financial position and results of operations.
Estimates and assumptions about future events and their effects cannot be determined with certainty. We base our estimates on historical experience and on various other assumptions believed to be applicable and reasonable under the circumstances. These estimates may change as new events occur, as additional information is obtained and as our operating environment changes. These changes have been included in the condensed consolidated financial statements as soon as they became known. In addition, management is periodically faced with uncertainties, the outcomes of which are not within its control and will not be known for prolonged periods of time. Certain of these uncertainties are discussed in our 2013 10-K in the sections entitled “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” Based on a critical assessment of our accounting policies and the underlying judgments and uncertainties affecting the application of those policies, management believes that our condensed consolidated financial statements are fairly stated in accordance with U.S. GAAP, and provide a fair presentation of our financial position and results of operations.
For more information, please see our critical accounting policies as previously disclosed in our 2013 10-K.
See Note 1 to the condensed consolidated financial statements included in this Quarterly Report on Form 10-Q regarding the impact of recent accounting pronouncements on our financial position and results of operations.
Results of Operations for the Three and Nine Month Periods Ended September 30, 2014 and 2013
We are a worldwide leader in the design, development, manufacture and support of defect inspection, advanced packaging lithography, process control metrology, and data analysis systems and software used by microelectronic device manufacturers. We provide process and yield management solutions used in both wafer processing and final manufacturing through a family of standalone systems for macro-defect inspection, lithography, probe card test and analysis, and transparent and opaque thin film measurements. All Rudolph systems feature sophisticated software and production-worthy automation. Rudolph systems are backed by worldwide customer support.
Rudolph’s business is affected by the annual spending patterns of our customers on semiconductor capital equipment. The amount that our customers devote to capital equipment spending depends on a number of factors, including general worldwide economic conditions as well as other economic drivers such as personal computer, tablet, cell phone, other personal electronic devices and automotive sales. Current forecasts by industry analysts for the semiconductor device manufacturing industry project a year-over-year increase in capital spending of approximately 5% to 10% for 2014. We monitor capital equipment spending through announced capital spending plans by our customers and monthly-published industry data such as the book-to-bill ratio. The book-to-bill ratio is a 3-month running statistic that compares bookings or orders placed with capital equipment suppliers to billings or shipments. A book-to-bill above 1.0 shows that semiconductor device equipment manufacturers are ordering equipment at a pace that exceeds the equipment suppliers’ shipments for the period. The 3-month rolling average North American semiconductor equipment book-to-bill ratio was 0.9 at September 30, 2014, a decrease from the book-to-bill ratio of 1.0 at December 31, 2013.
Historically, a significant portion of our revenues in each quarter and year has been derived from sales to relatively few customers, and we expect this trend to continue. For the nine month period ended September 30, 2014 and for the years ended December 31, 2013, 2012 and 2011, sales to customers that individually represented at least five percent of our revenues accounted for 36.0%, 41.6%, 50.9%, and 43.6% of our revenues, respectively.
We do not have purchase contracts with any of our customers that obligate them to continue to purchase our products, and they could cease purchasing products from us at any time. A delay in purchase or cancellation by any of our large customers could cause quarterly revenues to vary significantly. In addition, during a given quarter, a significant portion of our revenues may be derived from the sale of a relatively small number of systems. The following table lists the average selling price for our systems:
System | Average Selling Price Per System | |
Macro-defect inspection and probe card and test analysis | $250,000 to $1.7 million | |
Transparent film measurement | $800,000 to $1.2 million | |
Opaque film measurements | $1.0 million to $1.8 million | |
Lithography steppers | $3.0 million to $8.0 million | |
A significant portion of our revenues has been derived from customers outside of the United States. We expect that revenues generated from customers outside of the United States will continue to account for a significant percentage of our revenues.
18
The following table lists, for the periods indicated, the revenue derived from customers outside of the United States (in percentages of total revenues):
Nine Months Ended | |||||||||||
September 30, | Years Ended December 31, | ||||||||||
2014 | 2013 | 2012 | 2011 | ||||||||
Asia | 57.5 | % | 62.4 | % | 67.3 | % | 51.3 | % | |||
Europe | 12.6 | % | 14.4 | % | 13.4 | % | 20.4 | % | |||
Total international revenue | 70.1 | % | 76.8 | % | 80.7 | % | 71.7 | % | |||
The sales cycle for our systems typically ranges from six to 15 months, and can be longer when our customers are evaluating new technology. Due to the length of these cycles, we invest significantly in research and development and sales and marketing in advance of generating revenues related to these investments.
Revenues. Our revenues are primarily derived from the sale of our systems, services, spare parts and software licensing. Our revenue was $47.0 million and $131.6 million for the three and nine month periods ended September 30, 2014, compared to $44.0 million and $131.8 million for the three and nine month periods ended September 30, 2013. In the quarter-over-quarter period revenue increased 6.6% and in the year-over-year period revenue decreased 0.1%.
The following table lists, for the periods indicated, the different sources of our revenues in dollars (thousands) and as percentages of our total revenues:
Three Months Ended | Nine Months Ended | |||||||||||||||||||||||||||
September 30, | September 30, | |||||||||||||||||||||||||||
2014 | 2013 | 2014 | 2013 | |||||||||||||||||||||||||
Systems and Software: | ||||||||||||||||||||||||||||
Inspection | $ | 23,134 | 49 | % | $ | 21,734 | 49 | % | $ | 63,987 | 49 | % | $ | 73,441 | 55 | % | ||||||||||||
Metrology | 2,692 | 6 | % | 5,470 | 12 | % | 13,093 | 10 | % | 11,627 | 9 | % | ||||||||||||||||
Lithography | 7,304 | 16 | % | 3,618 | 8 | % | 10,961 | 8 | % | 7,318 | 6 | % | ||||||||||||||||
Data Analysis and Review | 5,463 | 12 | % | 4,724 | 11 | % | 18,393 | 14 | % | 13,737 | 10 | % | ||||||||||||||||
Parts | 4,939 | 10 | % | 5,235 | 12 | % | 15,051 | 11 | % | 16,036 | 13 | % | ||||||||||||||||
Services | 3,428 | 7 | % | 3,263 | 8 | % | 10,142 | 8 | % | 9,594 | 7 | % | ||||||||||||||||
Total revenue | $ | 46,960 | 100 | % | $ | 44,044 | 100 | % | $ | 131,627 | 100 | % | $ | 131,753 | 100 | % | ||||||||||||
Total systems and software revenue increased slightly for the nine months ended September 30, 2014 compared to the nine months ended September 30, 2013. Year-over-year there was decreased customer demand for our inspection systems which contributed to a lower number of inspection systems sold during the nine months ended September 30, 2014 as compared to the same period in the prior year. As a result, inspection systems revenue decreased $9.5 million for the 2014 period compared to the 2013 period. The number of metrology systems sold during the nine months ended September 30, 2014 was higher compared to the same period in the prior year, resulting in an increase in metrology systems revenue of $1.5 million for the 2014 period. Lithography system revenue increased $3.6 million for the nine months ended September 30, 2014, compared to the same period in the prior year, as we sold a JetStep®G system which has a higher average selling price than our other lithography systems. The year-over-year increase in data analysis and review software revenue for the nine months ended September 30, 2014 of $4.7 million is primarily due to increased sales in licensing revenue. As a result, the slight increase in total systems and software revenue for the 2014 period was caused by product mix of units shipped rather than pricing changes as the average selling price of similarly configured systems has been consistent across the year-over-year periods. Systems revenue generated by our latest product releases and major enhancements in each of our product families amounted to 67% and 61% of total revenues for the three and nine month periods ended September 30, 2014, compared to 58% and 64% of total revenues for the three and nine month periods ended September 30, 2013. The year-over-year decrease in total parts and services revenue for the nine month period ended September 30, 2014 is primarily due to decreased spending by our customers on system upgrades and repairs of existing systems. Parts and services revenues are generated from part sales, maintenance service contracts, system upgrades, as well as time and material billable service calls.
Deferred revenues of $8.5 million are recorded in the Condensed Consolidated Balance Sheets within the caption “Other current liabilities” at September 30, 2014 and primarily consist of $2.2 million for systems awaiting acceptance and outstanding deliverables and $6.3 million for deferred maintenance agreements.
19
Gross Profit. Our gross profit has been and will continue to be affected by a variety of factors, including manufacturing efficiencies, excess and obsolete inventory write-offs, pricing by competitors or suppliers, new product introductions, production volume, customization and reconfiguration of systems, international and domestic sales mix, and parts and service margins. Our gross profit was $25.0 million and $69.8 million for the three and nine month periods ended September 30, 2014, compared to $22.5 million and $67.9 million for the three and nine month periods ended September 30, 2013. Our gross profit represented 53.2% and 53.1% of our revenues for the three and nine month periods ended September 30, 2014 and 51.0% and 51.5% of our revenues for the same periods in the prior year. The increase in gross profit as a percentage of revenue for the three and nine month periods ended September 30, 2014 compared to the same period in the prior year is primarily due to product mix.
Operating Expenses. Major components of operating expenses include research and development as well as selling, general and administrative expenses.
Research and Development. Our research and development expense was $9.6 million and $30.5 million for the three and nine month periods ended September 30, 2014, compared to $10.5 million and $30.4 million for the same period in the prior year. Research and development expense represented 20.5% and 23.2% of our revenues for the three and nine month periods ended September 30, 2014, compared to 23.7% and 23.1% of revenues for the prior year period. The slight year-over-year dollar increase for the nine month period ended September 30, 2014 in research and development expenses primarily reflects an increase in compensation and project costs related to our lithography systems.
Selling, General and Administrative. Our selling, general and administrative expense was $10.3 million and $42.3 million for the three and nine month periods ended September 30, 2014, compared to $10.1 million and $30.8 million for the same period in the prior year. Selling, general and administrative expense represented 21.9% and 32.2% of our revenues for the three and nine month periods ended September 30, 2014, compared to 22.8% and 22.4% of our revenues for the same period in the prior year. The year-over-year dollar increase for the three and nine month periods ended September 30, 2014 in selling, general and administrative expense was primarily due to higher litigation expenses of $9.6 million related to the final judgment awarded to ITC. For further information, see Note 8 in the accompanying unaudited condensed consolidated financial statements.
Income Taxes. We recorded income tax provision of $3.8 million and income tax benefit of $3.1 million, for the three and nine month periods ended September 30, 2014, respectively. Our effective tax rate of 33.3% differs from the statutory rate of 35% for the nine month period ended September 30, 2014 primarily due to projected foreign tax expense in excess of foreign tax credits generated in 2014.
We currently have a partial valuation allowance recorded against our deferred tax assets. Each quarter we assess the likelihood that we will be able to recover our deferred tax assets primarily relating to state R&D credits. We consider available evidence, both positive and negative, including historical levels of income, expectations and risks associated with estimates of future taxable income and ongoing prudent and feasible tax planning strategies in assessing the need for a valuation allowance. As a result of our analysis, we concluded that it is more likely than not that a portion of our net deferred tax assets will not be realized. Therefore, we continue to provide a valuation allowance against certain net deferred tax assets. We continue to closely monitor available evidence and may reverse some or all of the valuation allowance in future periods, if appropriate.
Litigation. As discussed in Note 8 in the accompanying unaudited condensed consolidated financial statements and in Part II, Item 1 of this Quarterly Report on Form 10-Q (“Legal Proceedings”), we are subject to legal proceedings and claims, which include, among other things, our litigation with ITC in a patent infringement action related to the predictive scrub feature of our PrecisionPoint™, PrecisionWoRx® and ProbeWoRx® products in which we were the defendants (the “ITC Litigation”). See Note 8 in the accompanying unaudited condensed consolidated financial statements and Legal Proceedings for a discussion of this action and the District Court’s adverse order affirming the jury award and ordering other relief in this matter, the ruling obtained from the U.S. Federal Court of Appeals, the ruling by the U.S. Supreme Court, the Company’s payment in July 2014 of the assessed $10.6 million judgment, and the sole unresolved issue in the matter regarding the remanded attorney’s fees.
Liquidity and Capital Resources
At September 30, 2014, we had $162.5 million of cash, cash equivalents and marketable securities and $266.2 million in working capital. At December 31, 2013, we had $167.4 million of cash, cash equivalents and marketable securities and $265.3 million in working capital.
Operating activities used $2.0 million in net cash and cash equivalents for the nine month period ended September 30, 2014. The net cash and cash equivalents used in operating activities during the nine month period ended September 30, 2014 was primarily a result of changes in operating assets and liabilities of $11.4 million, partially offset by net loss, adjusted to exclude the effect of non-cash operating charges of $9.4 million. Operating activities used $4.0 million in net cash and cash equivalents for the nine month period ended September 30, 2013. The net cash and cash equivalents used in operating activities during the
20
nine month period ended September 30, 2013 was primarily a result of changes in operating assets and liabilities of $18.2 million, partially offset by net income adjusted to exclude the effect of non-cash operating charges of $14.2 million.
Net cash and cash equivalents used in investing activities during the nine month period ended September 30, 2014 of $28.8 million was due to the purchase of marketable securities of $172.3 million, and capital expenditures of $1.4 million, partially offset by the proceeds from sales of marketable securities of $145.0 million. Net cash and cash equivalents used in investing activities during the nine month period ended September 30, 2013 of $17.4 million was due to the purchase of marketable securities of $81.7 million, purchase of business of $3.4 million and capital expenditures of $4.0 million, partially offset by the proceeds from sales of marketable securities of $71.7 million.
In 2008, our Board of Directors approved a stock repurchase program of up to 3 million shares of Company common stock with no established end date. The program allows for repurchases to be made in the open market or through negotiated transactions from time to time. At September 30, 2014, 2.8 million shares remained available for future stock repurchases under this repurchase program. The shares of common stock purchased under the share repurchase program are being retired. For further information, see Note 15 in the accompanying unaudited condensed consolidated financial statements.
From time to time, we evaluate whether to acquire new or complementary businesses, products and/or technologies. We may fund all or a portion of the purchase price of these acquisitions in cash, stock, or a combination of cash and stock.
We had a $40 million irrevocable standby letter of credit available with Credit Suisse AG which was required to secure the damages assessment in connection with the ITC Litigation discussed in Legal Proceedings. On July 22, 2014, we paid $10.6 million to ITC through a draw down of the letter of credit. Pursuant to the terms of the letter of credit, upon draw down of the funds, the letter of credit was collateralized by securities held in the Company’s investment portfolios which were immediately sold to satisfy the letter of credit payment. The letter of credit was subsequently canceled upon completion of this payment.
Our future capital requirements will depend on many factors, including the timing and amount of our revenues and our investment decisions, which will affect our ability to generate additional cash. We believe that our existing cash, cash equivalents and marketable securities will be sufficient to meet our anticipated cash requirements for working capital and capital expenditures for the next twelve months. Thereafter, if cash generated from operations and financing activities is insufficient to satisfy our working capital requirements, we may seek additional funding through bank borrowings, sales of securities or other means. There can be no assurance that we will be able to raise any such capital on terms acceptable to us or at all.
Item 3. Quantitative and Qualitative Disclosures about Market Risk
Interest Rate and Credit Market Risk
We are exposed to changes in interest rates and market liquidity including our investments in certain available-for-sale securities. Our available-for-sale securities consist of fixed and variable rate income investments (municipal notes, municipal bonds and corporate bonds). We continually monitor our exposure to changes in interest rates, market liquidity and credit ratings of issuers from our available-for-sale securities. It is possible that we are at risk if interest rates, market liquidity or credit ratings of issuers change in an unfavorable direction. The magnitude of any gain or loss will be a function of the difference between the fixed or variable rate of the financial instrument and the market rate and our financial condition and results of operations could be materially affected. Based on a sensitivity analysis performed on our financial investments held as of September 30, 2014, an immediate adverse change of 10% in interest rates (e.g. 3.00% to 3.30%) would result in an immaterial decrease in the fair value of our available-for-sale securities and would not have a material impact on our consolidated financial position, results of operations or cash flows.
Foreign Currency Risk
We have branch operations in Taiwan, Singapore and South Korea and wholly-owned subsidiaries in Europe, China and Japan. Our international subsidiaries and branches operate primarily using local functional currencies. The intercompany transactions denominated in U.S. dollars appearing on the financial statements of the subsidiaries and branches are remeasured at each quarter-end resulting in gains and losses which are reflected in net income. A hypothetical 10% appreciation or depreciation in the U.S. dollar relative to the reporting currencies of our foreign subsidiaries at September 30, 2014 would have affected the foreign-currency-denominated non-operating expenses of our foreign subsidiaries by approximately $2.1 million. We cannot accurately predict future exchange rates or the overall impact of future exchange rate fluctuations on our business, results of operations and financial condition.
A substantial portion of our international sales are denominated in U.S. dollars with the exception of Japan and, as a result, we have relatively little exposure to foreign currency exchange risk with respect to these sales. Substantially all our sales in Japan are denominated in Japanese yen. From time to time, we may enter into forward exchange contracts to economically hedge a portion of, but not all, existing and anticipated foreign currency denominated transactions expected to occur within 12
21
months. The change in fair value of the forward contracts is recognized in “Other expense (income)” in the Condensed Consolidated Statements of Operations for each reporting period. As of September 30, 2014, we had eight forward contracts outstanding with a total notional contract value of $2.4 million. We do not use derivative financial instruments for trading or speculative purposes.
Item 4. Controls and Procedures
We maintain a set of disclosure controls and procedures, as defined in Rule 13a-15(e) or Rule 15d-15(e) under the Exchange Act, designed to ensure that information required to be disclosed by us in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms and that such information is accumulated and communicated to our management, including our Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”), as appropriate, to allow for timely decisions regarding required disclosure. The disclosure controls and procedures are designed to provide reasonable assurance of achieving the desired control objectives.
Scope of the Controls Evaluation
The evaluation of our disclosure controls and procedures included a review of the controls’ objectives and design, our implementation of the controls and the effect of the controls on the information generated for use in this Quarterly Report on Form 10-Q. In the course of the evaluation, we sought to identify data errors, control problems or acts of fraud and confirm that appropriate corrective actions, if any, including process improvements, were being undertaken. This type of evaluation is performed on a quarterly basis so that the conclusions of management, including the CEO and CFO, concerning the effectiveness of the controls can be reported in our Quarterly Reports on Form 10-Q and in our Annual Reports on Form 10-K. Many of the components of our disclosure controls and procedures are also evaluated on an ongoing basis by other personnel in our accounting, finance and legal functions. The overall goals of these various evaluation activities are to monitor our disclosure controls and procedures and to modify them on an ongoing basis as necessary. A control system can provide only reasonable, not absolute, assurance that the control system’s objectives will be met. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, have been detected. Over time, controls may become inadequate because of changes in conditions or deterioration in the degree of compliance with policies or procedures. Because of inherent limitations in a cost effective control system, misstatements due to error or fraud may occur and not be detected.
Conclusions
As of September 30, 2014, an evaluation of our disclosure controls and procedures was carried out under the supervision and with the participation of our management, including the CEO and CFO. Based on this evaluation, the CEO and CFO have concluded that our disclosure controls and procedures were effective at the reasonable assurance level as of the end of the period covered by this Quarterly Report on Form 10-Q.
Changes in Internal Control over Financial Reporting
There has been no change in our internal control over financial reporting that occurred during the period covered by this Quarterly Report on Form 10-Q that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
PART II OTHER INFORMATION
Item 1. Legal Proceedings
For a description of our previously reported legal proceedings refer to “Part I, Item 3 - Legal Proceedings” in our 2013 10-K, as updated in Note 8 to the accompanying unaudited condensed consolidated financial statements.
In our ITC Litigation, on June 30, 2014, the U.S. Supreme Court denied the Company’s Petition for a Writ of Certiorari to appeal the basis of the Federal Court of Appeals’ decision affirming the damages award for the pre-August 2007 tools. As a result, the Company paid to ITC $10.6 million on July 22, 2014. This matter is now fully resolved with the sole exception of the issue of remanded attorney’s fees. See Note 8 to the accompanying unaudited condensed consolidated financial statements for additional information regarding this action.
We are party to other ordinary and routine litigation incidental to our business. We do not expect the outcome of any pending litigation to have a material adverse effect on our consolidated financial position or results of operations.
22
Item 1A. Risk Factors
There were no material changes to our risk factors as discussed in Part I, Item 1A - Risk Factors in our 2013 10-K.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
In 2008, our Board of Directors authorized a share repurchase program of up to 3 million shares of the Company’s common stock with no established end date. The program allows for repurchases to be made in the open market or through negotiated transactions from time to time. At September 30, 2014, 2,762 shares remained available for future stock repurchases under this repurchase program. The shares of common stock purchased under the share repurchase program are being retired.
The following table provides details of common stock purchased during the three month period ended September 30, 2014 (in thousands, except per share data):
Period | Total Number of Shares Purchased | Average Price Paid per Share | Total Number of Shares Purchased as Part of Publicly Announced Program | Maximum Number of Shares that May Yet Be Purchased Under the Program | |||||||||
July 1, 2014 - July 31, 2014 | 75 | $ | 9.87 | 75 | 2,825 | ||||||||
August 1, 2014 - August 31, 2014 | — | — | — | 2,825 | |||||||||
September 1, 2014 - September 30, 2014 | 63 | $ | 9.66 | 63 | 2,762 | ||||||||
Three months ended September 30, 2014 | 138 | $ | 9.78 | 138 | 2,762 | ||||||||
Item 3. Defaults Upon Senior Securities
None.
Item 4. Mine Safety Disclosures
None.
Item 5. Other Information
None.
23
Item 6. Exhibits
Exhibit No. | Description |
10.1 | Form of Restricted Stock Agreement pursuant to the Rudolph Technologies, Inc. 2009 Stock Plan. |
10.2 | Restated and Amended Management Agreement, dated as of July 29, 2014, by and between Rudolph Technologies, Inc. and Paul F. McLaughlin (incorporated by reference to Exhibit 10.1 to the Registrant’s Quarterly Report on Form 10-Q (SEC File No. 000-27965) filed on August 6, 2014). * |
10.3 | Restated and Amended Management Agreement, dated as of July 29, 2014, by and between Rudolph Technologies, Inc. and Steven R. Roth (incorporated by reference to Exhibit 10.1 to the Registrant’s Quarterly Report on Form 10-Q (SEC File No. 000-27965) filed on August 6, 2014). * |
10.4 | Restated and Amended Employment Agreement, dated as of July 29, 2014, by and between Rudolph Technologies, Inc. and Michael Plisinski (incorporated by reference to Exhibit 10.1 to the Registrant’s Quarterly Report on Form 10-Q (SEC File No. 000-27965) filed on August 6, 2014). * |
10.5 | Restated and Amended Employment Agreement, dated as of July 29, 2014, by and between Rudolph Technologies, Inc. and D. Mayson Brooks (incorporated by reference to Exhibit 10.1 to the Registrant’s Quarterly Report on Form 10-Q (SEC File No. 000-27965) filed on August 6, 2014). * |
31.1 | Certification of Paul F. McLaughlin, Chief Executive Officer, pursuant to Securities Exchange Act Rule 13a-14(a). |
31.2 | Certification of Steven R. Roth, Chief Financial Officer, pursuant to Securities Exchange Act Rule 13a-14(a). |
32.1 | Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, signed by Paul F. McLaughlin, Chief Executive Officer of Rudolph Technologies, Inc. |
32.2 | Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, signed by Steven R. Roth, Chief Financial Officer of Rudolph Technologies, Inc. |
101.INS | XBRL Instance Document |
101.SCH | XBRL Taxonomy Extension Schema Document |
101.CAL | XBRL Taxonomy Extension Calculation Linkbase Document |
101.DEF | XBRL Taxonomy Extension Definition Linkbase Document |
101.LAB | XBRL Taxonomy Extension Label Linkbase Document |
101.PRE | XBRL Taxonomy Extension Presentation Linkbase Document |
* Management contract, compensatory plan or arrangement. | |
24
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Rudolph Technologies, Inc. | |||
Date: | November 6, 2014 | By: | /s/ Paul F. McLaughlin |
Paul F. McLaughlin | |||
Chairman and Chief Executive Officer | |||
Date: | November 6, 2014 | By: | /s/ Steven R. Roth |
Steven R. Roth | |||
Senior Vice President, Chief Financial Officer and Principal Accounting Officer | |||
25
EXHIBIT INDEX
Exhibit No. | Description |
10.1 | Form of Restricted Stock Agreement pursuant to the Rudolph Technologies, Inc. 2009 Stock Plan. |
10.2 | Restated and Amended Management Agreement, dated as of July 29, 2014, by and between Rudolph Technologies, Inc. and Paul F. McLaughlin (incorporated by reference to Exhibit 10.1 to the Registrant’s Quarterly Report on Form 10-Q (SEC File No. 000-27965) filed on August 6, 2014). * |
10.3 | Restated and Amended Management Agreement, dated as of July 29, 2014, by and between Rudolph Technologies, Inc. and Steven R. Roth (incorporated by reference to Exhibit 10.1 to the Registrant’s Quarterly Report on Form 10-Q (SEC File No. 000-27965) filed on August 6, 2014). * |
10.4 | Restated and Amended Employment Agreement, dated as of July 29, 2014, by and between Rudolph Technologies, Inc. and Michael Plisinski (incorporated by reference to Exhibit 10.1 to the Registrant’s Quarterly Report on Form 10-Q (SEC File No. 000-27965) filed on August 6, 2014). * |
10.5 | Restated and Amended Employment Agreement, dated as of July 29, 2014, by and between Rudolph Technologies, Inc. and D. Mayson Brooks (incorporated by reference to Exhibit 10.1 to the Registrant’s Quarterly Report on Form 10-Q (SEC File No. 000-27965) filed on August 6, 2014). * |
31.1 | Certification of Paul F. McLaughlin, Chief Executive Officer, pursuant to Securities Exchange Act Rule 13a-14(a). |
31.2 | Certification of Steven R. Roth, Chief Financial Officer, pursuant to Securities Exchange Act Rule 13a-14(a). |
32.1 | Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, signed by Paul F. McLaughlin, Chief Executive Officer of Rudolph Technologies, Inc. |
32.2 | Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, signed by Steven R. Roth, Chief Financial Officer of Rudolph Technologies, Inc. |
101.INS | XBRL Instance Document |
101.SCH | XBRL Taxonomy Extension Schema Document |
101.CAL | XBRL Taxonomy Extension Calculation Linkbase Document |
101.DEF | XBRL Taxonomy Extension Definition Linkbase Document |
101.LAB | XBRL Taxonomy Extension Label Linkbase Document |
101.PRE | XBRL Taxonomy Extension Presentation Linkbase Document |
* Management contract, compensatory plan or arrangement. | |
26